Search results
Results from the WOW.Com Content Network
Gonzalez, 70, who has been at the company's helm since it was formed through a spin-off from Abbott in 2013, will become executive chairman of AbbVie's board once he steps down.
This spin-off company, named AbbVie, was formed on April 10, 2012. [8] ... Abbvie (Spin off from Abbott Laboratories) Pharmacyclics (Acq 2015) Stemcentrx (Acq 2016)
And since it split from Abbott in 2013, AbbVie has increased its dividend by 310%. The stock's forward yield is now around 3.8%, compared to the S&P 500 's average of 1.3%.
Spin-off entity Transaction value (in billions USD) Inflation adjusted (in billions 2022 USD) Ref 1 2024 General Electric Company: GE Aerospace, GE Vernova, GE Healthcare: 191 191 [1] 2 2008 Altria Group: Philip Morris International: 108 141 [2] [3] 3 2000 BCE: Nortel: 60 97 [3] 4 2013 Abbott Laboratories: AbbVie: 56 67 [3] 5 2015 eBay: PayPal ...
Today, AbbVie stock trades at a forward price-to-earnings (P/E) ratio under 15. That's a solid deal for a company with 8% expected growth and a dividend yielding 3.5% at its current share price.
Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois.It had approximately 19,000 employees. [1] Before its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals, [2] manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication ...
Since its spinoff from Abbott Labs in 2013, AbbVie has increased its dividend payout by 310%. The big drugmaker's forward dividend yield currently stands at nearly 3.6%. That's on the low end of ...
Abbott Laboratories (NYS: ABT) is in the midst of some dramatic new plans. The company will soon spin off its branded pharmaceuticals business into a new entity called AbbVie. The original Abbott ...